Skip to Content
Merck
CN
  • The Alazami Syndrome-Associated Protein LARP7 Guides U6 Small Nuclear RNA Modification and Contributes to Splicing Robustness.

The Alazami Syndrome-Associated Protein LARP7 Guides U6 Small Nuclear RNA Modification and Contributes to Splicing Robustness.

Molecular cell (2020-02-06)
Daniele Hasler, Rajyalakshmi Meduri, Maciej Bąk, Gerhard Lehmann, Leonhard Heizinger, Xin Wang, Zhi-Tong Li, François M Sement, Astrid Bruckmann, Anne-Catherine Dock-Bregeon, Rainer Merkl, Reinhard Kalb, Eva Grauer, Erdmute Kunstmann, Mihaela Zavolan, Mo-Fang Liu, Utz Fischer, Gunter Meister
ABSTRACT

The La-related protein 7 (LARP7) forms a complex with the nuclear 7SK RNA to regulate RNA polymerase II transcription. It has been implicated in cancer and the Alazami syndrome, a severe developmental disorder. Here, we report a so far unknown role of this protein in RNA modification. We show that LARP7 physically connects the spliceosomal U6 small nuclear RNA (snRNA) with a distinct subset of box C/D small nucleolar RNAs (snoRNAs) guiding U6 2'-O-methylation. Consistently, these modifications are severely compromised in the absence of LARP7. Although general splicing remains largely unaffected, transcriptome-wide analysis revealed perturbations in alternative splicing in LARP7-depleted cells. Importantly, we identified defects in 2'-O-methylation of the U6 snRNA in Alazami syndrome siblings carrying a LARP7 mutation. Our data identify LARP7 as a bridging factor for snoRNA-guided modification of the U6 snRNA and suggest that alterations in splicing fidelity contribute to the etiology of the Alazami syndrome.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
1-Methylimidazole, ReagentPlus®, 99%
Sigma-Aldrich
Anti-RNA polymerase II subunit B1 (phospho CTD Ser-2) Antibody, clone 3E10, clone 3E10, from rat
Millipore
ANTI-FLAG® M2 Affinity Gel, purified immunoglobulin, buffered aqueous glycerol solution